+ND Capital has exited Dutch cell therapy company CellPoint by sale to the Belgian biotech company Galapagos which has acquired CellPoint for $131 million upfront and up to $105 million in milestone payments. As sole venture investor
Tags :Luc Defferrard
XS Participations, a Dutch investment company, has agreed to sell its stake in Twelve Capital Holding, an independent investment manager specializing in investments in the insurance sector, to Graubündner Kantonalbank and management of Twelve
Forterro, a European provider of ERP software solutions to nearly 8,000 midmarket manufacturing and production companies, acquired myfactory, a provider of cloud-based ERP. The acquisition expands Forterro’s total addressable market in DACH, and nearly
Rakuten Group, a global innovation company listed on the Tokyo Stock Exchange, has entered into an agreement in 2016 to acquire a substantial minority stake in getAbstract, a global company specializing in compressed digital content. On 02
Ultra Forensic Technology (UFT) has agreed to sell its Switzerland based Projectina business (Projectina) to UK-based private equity and advisory firm, Heligan Group. As a niche forensic and security-focused optical engineering business, Projectina has been
Novartis has acquired Arctos Medical, adding a pre-clinical optogenetics-based AAV gene therapy program and Arctos’ proprietary technology to its ophthalmology portfolio. The acquisition underscores the Novartis commitment to finding treatments for patients with vision loss
The partners and long-term employees of Schweizerische Treuhandgesellschaft in Basel have acquired the local entity from the current owners through a Management Buy-Out (Mbo). With the Mbo of the largest Stg-unit in Basel which occurred
Walder Wyss advised Groupe Mutuel on this transaction. The team was led by Luc Defferrard (Partner, Corporate / M&A - pictured) and Rafael Zemp (Managing Associate, Corporate / M&A)
Walder Wyss advised Crédit Mutuel Equity in relation to this investment. The team was led by partner Luc Defferrard (M&A)
